Issue 1, 1977

Crystal and molecular structure of the histamine H2-receptor antagonists, N-methyl-N′-{2-[(5-methylimidazol-4-yl)methylthio]ethyl}thiourea (metiamide) and N-{2-[(imidazol-4-yl)methylthio]ethyl}-N′-methylthiourea (thiaburimamide)

Abstract

The crystal and molecular structures of the title compounds have been determined from three-dimensional X-ray diffractometer data by direct methods. Metiamide (Ia) is monoclinic, P21/n(b unique), Z= 4, a= 10.229 ± 0.008, b= 19.045 ± 0.009, c= 6.701 ± 0.003 Å, β= 107.76°± 0.004. Thiaburimamide (Ic) is also monoclinic, space goup P21/c(b unique)Z= 4, a= 9.981 ± 0.003, b= 5.928 ± 0.003, c= 20.396 ± 0.007 Å, β= 105.36 ± 0.02°. Data were refined by least-squares to R= 4.4% in both cases (2 226 and 2 903 independent reflections). Both molecules are internally hydrogen bonded by an N ⋯ H–N bond between the imidazole and thiourea residues, forming a ten-membered ring system. These molecules are further agglomerated in continuous hydrogen-bonded networks. In (Ic) the molecules are linked in pairs by S ⋯ H–N bonds and further into infinite ribbons parallel to c. (Ia) is similarly involved in a complex hydrogen-bonding pattern, to form sheets. These differences are reflected in the relative crystal stabilities, as judged from m.p.s and aqueous solubilities. The compounds are compared with those having CH2 in place of the thioether S linkage, viz. burimamide (Ib) and its 5-methyl derivative (Id). Solid-state i.r. spectra indicate that (Id), like (Ib) does not form the intramolecular hydrogen-bond in the crystal. Thus it appears that the thioether linkage may increase conformational flexibility and favour folding of the side-chain; these effects may contribute to the increased activity of the title compounds as histamine H2-receptor antagonists.

Article information

Article type
Paper

J. Chem. Soc., Perkin Trans. 2, 1977, 68-75

Crystal and molecular structure of the histamine H2-receptor antagonists, N-methyl-N′-{2-[(5-methylimidazol-4-yl)methylthio]ethyl}thiourea (metiamide) and N-{2-[(imidazol-4-yl)methylthio]ethyl}-N′-methylthiourea (thiaburimamide)

K. Prout, S. R. Critchley, C. R. Ganellin and R. C. Mitchell, J. Chem. Soc., Perkin Trans. 2, 1977, 68 DOI: 10.1039/P29770000068

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements